Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
DHTV
Popular
Top Rated

Related Complications & Care Videos on Diabetes Health TV

Close Encounter - A Profile of a Diabetes Patient and Business Insider

Kelly Close

Close Encounter - A Profile of a Diabetes Patient and Business Insider

Injection Site Awareness Week

Dr. Stuart Bootle, MB ChB

Injection Site Awareness Week

Merino intensive skin care products

Judy Reber

Merino intensive skin care products

View all Videos…
Insulin Resistance Archives
Browse the Insulin Resistance Archives
Subscribe to the Complications & Care RSS Feed

Insulin Resistance

Complications & Care RSS Feed RSS
Updated 28 weeks ago
 
Study Reports That “Fat but Fit” Is Not an Oxymoron
news
Study Reports That “Fat but Fit” Is Not an Oxymoron

While there is an almost constant media drumbeat about the dangers of obesity and overweight, it's a pleasure to learn that not everyone who is overweight is in bad health or runs the risk of it.

Comments 0 comments - Nov 7, 2012 - * * * * *

Mayo Clinic Says Simple Lifestyle Changes Can Forestall Type 2
news
Mayo Clinic Says Simple Lifestyle Changes Can Forestall Type 2

The Mayo Clinic Health Letter for August 2012 has published three lifestyle changes that could stave off the progression of prediabetes to full-blown type 2 diabetes. The list isn't new, but its periodic reiteration indicates that healthcare researchers and providers have settled on a simple prescription for staying diabetes-free.

Comments 1 comment - Sep 4, 2012 - * * * * *

US Sale of Generic Actos Gets FDA Nod
news
US Sale of Generic Actos Gets FDA Nod

The Food and Drug Administration has approved US sale of generic pioglitazone (trade name Actos) for the treatment of type 2 diabetes. Actos, originally developed and trademarked by Takeda Pharmaceuticals, works by decreasing insulin resistance in type 2 patients. The prescription drug, which belongs to the class of drugs known as thiazolidinediones (TZDs), has enjoyed great commercial success in the United States since its introduction in 1999, posting estimated sales last year of $2.7 billion.

Comments 0 comments - Aug 27, 2012 - * * * * *

 
©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.